BPC-157 5mg/vial 1 Vial by Bio-Peptide

Usage

1. Reconstitute the 5 mg lyophilized vial by injecting 1–2 mL bacteriostatic water slowly along the glass wall — do not shake.
2. Swirl gently until fully dissolved (≈ 60 seconds); the solution should be clear and colourless.
3. For local injection: identify the target tendon or joint, clean the skin with an alcohol swab, and inject within 1–3 cm of the injury site using a 27–29 gauge insulin syringe.
4. For systemic injection: pinch abdominal subcutaneous fat, insert a 29 gauge insulin syringe at 45°, and administer the calculated dose slowly.
5. Rotate injection sites with every administration to minimise local irritation; keep a daily log of sites used.
6. Store reconstituted vials at 2–8 °C and use within 28 days; discard any vial that shows cloudiness, discolouration, or visible particles.

Warnings

Frequently asked questions

How does BPC-157 promote healing in damaged tendons and ligaments?

BPC-157 stimulates tendon fibroblast proliferation and upregulates collagen type-I synthesis, restoring tensile strength to injured connective tissue. It also triggers VEGF-driven angiogenesis, re-establishing blood flow in avascular tendon zones. Studies in rodent models show measurable structural tendon recovery within 14 days at doses of 10 µg/kg, a response not observed in saline controls over the same window.

Should I inject BPC-157 locally near the injury or use systemic subcutaneous injections?

Local peri-articular or intratendinous injection is preferred for discrete, accessible injuries — such as patellar tendinopathy or elbow tendinitis — because it concentrates the peptide directly at the repair site. Systemic subcutaneous injection in abdominal fat is better suited to diffuse injuries, multiple sites, or when precise local delivery is impractical. Many practitioners use systemic dosing daily and add a local injection two to three times per week at the primary injury.

How long does a typical BPC-157 tendon healing protocol last?

Most research-informed protocols run four to six weeks for tendon and joint injuries, with measurable improvements in pain and range of motion often reported by week two. Acute injuries may respond within three to four weeks, while chronic tendinopathies or post-surgical recovery can benefit from an extended eight-week run. A post-protocol rest period of two to four weeks is recommended before reassessment.

How do I reconstitute and store Bio-Peptide BPC-157 5mg/vial correctly?

Add 1–2 mL of bacteriostatic water slowly along the vial wall — never shake, swirl gently. The 5 mg lyophilized powder dissolves into a clear solution within 60 seconds. Store reconstituted vials refrigerated at 2–8 °C and use within 28 days; discard if the solution appears cloudy or particulate. Unreconstituted vials should be kept at −20 °C for long-term stability.

Why choose a 5mg/vial concentration of BPC-157 rather than a higher-dose vial?

The 5 mg vial is the entry-level concentration in the Bio-Peptide BPC-157 range, making it ideal for users running lower daily doses of 250–500 µg, where a single vial provides 10–20 administrations. It also minimises waste: smaller aliquots reduce freeze-thaw cycles that degrade peptide potency. For practitioners new to BPC-157, the 5 mg vial allows careful dose titration before committing to higher-volume formats. (2) angle_used

Manufacturer

Bio-Peptide is a European peptide manufacturer that entered the research compound market with a focus on pharmaceutical-grade synthesis standards applied to lyophilized peptide vials. The company built its reputation around stringent batch-level quality control — commissioning independent third-party HPLC purity verification and LAL endotoxin screening for every production run rather than relying on in-house testing alone. Bio-Peptide's manufacturing infrastructure operates under cGMP guidelines, with full chain-of-custody documentation from raw amino-acid procurement through to final vial labelling and cold-chain dispatch. Their catalogue centres on peptides with documented peer-reviewed research backgrounds, positioning the brand toward researchers and advanced practitioners who prioritise traceability and analytical transparency over price-competitive, unverified alternatives.